Delivery Order SPE2DB20D7066-SPE2DB25FC4MV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,374.48 to AmerisourceBergen Drug Corp for Estring 7.5 microgram per day contraceptive rings (2 milligram dosage) on June 30, 2025, with completion scheduled for July 1, 2025. This non-compete, firm fixed price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,290.80 to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings. The contract, issued on September 18, 2025, with completion targeted for September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,944.85 delivery order to AmerisourceBergen Drug Corp for Estring 7.5 micrograms/day contraceptive rings (2 mg dosage). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 1, 2025. The award was issued on June 30, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $4,856.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2mg) contraceptive vaginal rings. This is a non-set-aside competitive award with an ultimate completion date of August 25, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency awarded a $2,690.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day contraceptive rings (2mg dosage) on August 26, 2025, with completion scheduled for August 27, 2025. The contract was awarded without a set-aside designation through open competition and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings with a ceiling value of $3,289.23. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- This delivery order awards AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, a contract valued at $4,645.68 for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings. The award is a firm fixed price delivery order with no set-aside designation, issued under a competitive process by the Defense Logistics Agency's Medical Supply Chain. The ultimate completion date is September 19, 2025, with the work performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,681.00 delivery order for Estring 7.5 mcg/day (2mg) rings under a firm fixed-price contract. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a child contract with no set-aside designation, competitively awarded through open competition. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,345.05 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 11, 2025, with completion by August 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,185.30, is for the delivery of ESTRING 7.5 MCG/DAY (2MG) RINGS, with a period of performance through November 21, 2023. This delivery order is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4MVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Estring 7.5 mcg/day contraceptive vaginal rings with a ceiling value of $1,374.48. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a non-competitive set-aside transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive product portfolio spanning brand-name and generic medications, vaccines, and specialized medical devices. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support Defense Health Agency and other federal healthcare systems globally. As a child contract under this substantial prime IDV, the Estring delivery order exemplifies the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to support military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/26/25 |